Sam Brusco, Associate Editor06.21.22
eCential Robotics, a French company that makes a unified 2D/3D robotic imaging and surgical navigation for bone surgery, has begun a long-term partnership with spinal implant firm ChoiceSpine.
The two companies aim to offer a common optimized solution combining navigation, robotics, and implant systems.
eCential’s Robotics platform pulls together intraoperative 2D/3D imaging, navigation, and robotics on a single device. The open solution can cater to surgeon preference, and it’s built around a range of applications dedicated to spine surgery.
The company plans to pursue multiple bone surgery indications soon. The company’s 2D/3D robotic imaging earned FDA clearance last year, and the company conducted preclinical tests in the U.S. with neurosurgeons and orthopedic surgeons in Q1 2022. The firm has also launched the process to gain clearance for its navigation and collaborative robot (CoBot).
ChoiceSpine’s portfolio of hardware includes the Thunderbolt minimally invasive pedicle screw system and the Triton 3D-printed SI joint fixation system, BioBond 3D-printed interbodies, a shallow docking access system for direct lateral surgery, and multiple cervical fusion options. The orthobiologics portfolio offers 100% demineralized bone matrix, cortical fibers, synthetics, a cellular bone matrix, structural allograft, and allograft sponge options.
Navigation and robotics will make it possible to use specific features of ChoiceSpine’s portfolio.
"By enabling eCential Robotics' platform to navigate ChoiceSpine implants with our robotic arm, we will optimize and add value to our unified and universal solution for the benefit of surgeons and patients," said Laurence Chabanas, eCential Robotics’ chief strategy officer told the press. "This partnership is a part of eCential Robotics' open model strategy. Since our ambition is to offer a unique platform for bone surgery in the operating room and become a standard, we are open to collaborating with implant companies to combine our technologies and offer optimized navigation and robotics for the implementation proposed to the patient."
Steve Ainsworth, Ph.D., ChoiceSpine's EVP of strategy and technology, added: "This combination of our innovative cultures will allow us to expand our clinical value by fully encompassing the surgical experience. We believe the eCential Robotics platform, in conjunction with our comprehensive spinal implant and orthobiologics portfolios, will lead the way in advancing spine surgery. This partnership is just one example of how ChoiceSpine brings technically superior spinal devices to the market and is doing spine the right way."
The two companies aim to offer a common optimized solution combining navigation, robotics, and implant systems.
eCential’s Robotics platform pulls together intraoperative 2D/3D imaging, navigation, and robotics on a single device. The open solution can cater to surgeon preference, and it’s built around a range of applications dedicated to spine surgery.
The company plans to pursue multiple bone surgery indications soon. The company’s 2D/3D robotic imaging earned FDA clearance last year, and the company conducted preclinical tests in the U.S. with neurosurgeons and orthopedic surgeons in Q1 2022. The firm has also launched the process to gain clearance for its navigation and collaborative robot (CoBot).
ChoiceSpine’s portfolio of hardware includes the Thunderbolt minimally invasive pedicle screw system and the Triton 3D-printed SI joint fixation system, BioBond 3D-printed interbodies, a shallow docking access system for direct lateral surgery, and multiple cervical fusion options. The orthobiologics portfolio offers 100% demineralized bone matrix, cortical fibers, synthetics, a cellular bone matrix, structural allograft, and allograft sponge options.
Navigation and robotics will make it possible to use specific features of ChoiceSpine’s portfolio.
"By enabling eCential Robotics' platform to navigate ChoiceSpine implants with our robotic arm, we will optimize and add value to our unified and universal solution for the benefit of surgeons and patients," said Laurence Chabanas, eCential Robotics’ chief strategy officer told the press. "This partnership is a part of eCential Robotics' open model strategy. Since our ambition is to offer a unique platform for bone surgery in the operating room and become a standard, we are open to collaborating with implant companies to combine our technologies and offer optimized navigation and robotics for the implementation proposed to the patient."
Steve Ainsworth, Ph.D., ChoiceSpine's EVP of strategy and technology, added: "This combination of our innovative cultures will allow us to expand our clinical value by fully encompassing the surgical experience. We believe the eCential Robotics platform, in conjunction with our comprehensive spinal implant and orthobiologics portfolios, will lead the way in advancing spine surgery. This partnership is just one example of how ChoiceSpine brings technically superior spinal devices to the market and is doing spine the right way."
